Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:23 pm
Tags:
Actavis, Celgene, Amgen, AbbVie, Gilead Sciences, Eli Lilly, Novartis, AstraZeneca, Merck, JNJ, Biogen Idec, Novo Nordisk, Roche, Bristol-Myers Squibb, Pfizer, GSK, Sanofi
Gilead Sciences, Inc. Can't Do It Alone
Motley Fool
Mon, 12/29/14 - 09:10 pm
Tags:
Gilead Sciences, HIV, JNJ
3 Pharma Giants Growing Significantly Faster Than GlaxoSmithKline PLC
Motley Fool
Fri, 12/26/14 - 10:26 pm
Tags:
GSK, Amgen, Celgene, JNJ
Johnson & Johnson's Immunology Pipeline Is Golden
Seeking Alpha
Mon, 12/22/14 - 04:51 pm
Tags:
JNJ, immunology, Stelara, sirukumab, CNTO 6785
MacroGenics Partners With J&J; Stock Jumps
Investors.com
Mon, 12/22/14 - 01:17 pm
Tags:
Macrogenics, JNJ, Janssen Biotech, MGD011
J&J rents Halozyme's R&D technology for up to $581M
Fierce Biotech
Wed, 12/17/14 - 09:32 pm
Tags:
JNJ, Halozyme, R&D, Enhanze, Janssen Biotech
Is this the future of late-stage drug development? Lets hope so!
Forbes
Mon, 12/15/14 - 10:19 am
Tags:
R&D, drug development, Stelara, JNJ, psoriasis, Novartis, Cosentyx
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Tags:
Novartis, Amgen, JNJ, Stelara, psoriasis, brodalumab, Cosentyx
Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval
Fierce Biotech
Fri, 12/12/14 - 08:51 am
Tags:
Novartis, psoriasis, JNJ, Stelara, secukinumab
One shot or two? Many questions unresolved in Ebola vaccine race
Yahoo/Reuters
Thu, 12/11/14 - 08:38 am
Tags:
ebola virus, vaccines, GSK, NewLink Genetics, JNJ, Merck
Covidien Loses $176M Award in Patent Case Against JNJ Unit
Yahoo/Zacks.com
Tue, 12/9/14 - 10:12 pm
Tags:
Covidien, patents, JNJ, devices, Ethicon
Update: FDA Clears Johnson & Johnson's Insulin Pump, An Artificial Pancreas Quickened
Seeking Alpha
Fri, 12/5/14 - 03:38 pm
Tags:
FDA, devices, diabetes, JNJ, insulin pump, Animas Vibe, artificial pancreas
U.S. appeals court tosses $176 mln award for Covidien in patent case
Yahoo/Reuters
Thu, 12/4/14 - 05:45 pm
Tags:
Covidien, JNJ, Dune Medical Devices
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
Thu, 12/4/14 - 10:47 am
Tags:
JNJ, lymphoma, daratumumab, Genmab, non-Hodgkin's lymphoma
Johnson & Johnson Bought Alios for Hepatitis C
Motley Fool
Thu, 12/4/14 - 10:41 am
Tags:
JNJ, Alios BioPharma, M&A, hepatitis C
J&J looks for Xarelto boost in real-world cost data
Fierce Pharma Marketing
Thu, 12/4/14 - 10:21 am
Tags:
JNJ, Xarelto, bloodthinners
J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
Fierce Biotech
Tue, 12/2/14 - 09:25 am
Tags:
JNJ, Astellas, rheumatoid arthritis, ASP015K, JAK inhibitors
J&J bets up to $277M on a prospect from its R&D farm system
Fierce Biotech
Mon, 12/1/14 - 11:19 am
Tags:
JNJ, R&D, Modern Biosciences
Who are the stars of personalized medicine? Roche, Novartis and J&J
Fierce Pharma Marketing
Wed, 11/26/14 - 11:43 am
Tags:
personalized medicine, Roche, Novartis, JNJ
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wed, 11/26/14 - 11:38 am
Tags:
Amgen, AstraZeneca, brodalumab, JNJ, Stelara, psoriasis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.